TP53 and gastric cancer: In summary, a novel electrochemical immune detection system based on microfluidic chip was developed for simultaneous detecting multiple biomarkers (CEA, CA19-9, H.P., P53, PG I, and PG II) for early diagnosis of gastric cancer.